The GABA(B) receptor antagonist CGP 36 742 and the nootropic oxiracetam facilitate the formation of long-term memory

被引：42

作者：

Mondadori, C ^{[1
]}

Mobius, HJ ^{[1
]}

Borkowski, J ^{[1
]}

机构：

[1] CIBA GEIGY AG,PHARMACEUT RES DEPT,CH-4002 BASEL,SWITZERLAND

来源：

BEHAVIOURAL BRAIN RESEARCH | 1996年 / 77卷 / 1-2期

关键词：

CGP; 36; 742; GABA(B); oxiracetam; memory; mouse;

D O I：

10.1016/0166-4328(95)00222-7

中图分类号：

B84 [心理学]; C [社会科学总论]; Q98 [人类学];

学科分类号：

03 ; 0303 ; 030303 ; 04 ; 0402 ;

摘要：

The memory-enhancing effects of a single treatment with the GABA, antagonist CGP 36 742 (10 mg/kg) or the nootropic agent oxiracetam (100 mg/kg) given immediately after a learning experience ('post-trial') remain detectable for at least 4 months thereafter. This indicates that in all probability these substances facilitate the formation of the long-term memory trace.

引用

页码：223 / 225

页数：3

共 44 条

[31] Microinjections of the dopamine D2 receptor antagonist sulpiride into the medial prefrontal cortex attenuate glucocorticoid-induced impairment of long-term memory retrieval in rats
Pakdel, Roghayeh
Rashidy-Pour, Ali
NEUROBIOLOGY OF LEARNING AND MEMORY, 2007, 87 (03) : 385 - 390
[32] Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats
Rowe, WB
O'Donnell, JP
Pearson, D
Rose, GM
Meaney, MJ
Quirion, R
BEHAVIOURAL BRAIN RESEARCH, 2003, 145 (1-2) : 171 - 178
[33] The essential role of baf53b in learning-related synaptic plasticity and long-term fear memory formation in the lateral amygdala
Yoo, M.
Choi, K. -Y.
Shim, J.
Choi, J. -H.
Kim, J.
Oh, J.
Kaang, B. -K.
Han, J. -H.
JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 381 - 381
[34] FINE-STRUCTURAL CHANGES IN THE SUPERIOR CERVICAL-GANGLION OF ADULT-RATS AFTER LONG-TERM ADMINISTRATION OF BACLOFEN, A GABA-B RECEPTOR AGONIST
PARDUCZ, A
JOO, F
SIKLOS, L
WOLFF, JR
NEUROSCIENCE, 1990, 36 (01) : 239 - 245
[35] GABA(B) RECEPTOR ACTIVATION, INTRACELLULAR CA++ DECREASE, INHIBITION OF PROTEIN-KINASES - POSSIBLE MECHANISMS OF LONG-TERM POSTTETANIC MODIFICATION OF THE EFFICACY OF INHIBITORY TRANSMISSION IN NEOCORTEX
SILKIS, IG
ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA, 1995, 45 (01) : 18 - 28
[36] Long-term efficacy and safety of oral deucrictibant, a bradykinin b2 receptor antagonist, in treatment of hereditary angioedema attacks: Results of the rapide-2 extension study
Aygoeren-Pirsin, E.
Bouillet, L.
Chapdelaine, H.
Farkas, H.
Gobert, D.
Hakl, R.
Lleonart, R.
Reshef, A.
Spadaro, G.
Ka, M. Staevs-
Stobiecki, M.
Valerieva, A.
Sun, J.
Zhu, L.
Yu, M.
Nattasio, G. Gian-
Lu, P.
Maurer, M.
ALLERGOLOGIE, 2024, 47 (09)
[37] Long-term safety of anakinra (interleukin-1 receptor antagonist) in patients receiving standard therapy for rheumatoid arthritis: Final result from a 36-month large phase III study
Fleischmann, RM
Burmester, GR
Modafferi, D
Zhou, L
Appleton, B
Bekker, P
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 281 - 281
[38] Long-term safety of anakinra (Interleukin-1 receptor antagonist) in patients receiving standard treatments for Rheumatoid Arthritis: A 36-month update from a large phase 3 study.
Fleischmann, RM
Tesser, JRP
Bekker, P
Bell, D
Zhou, LF
Modafferi, D
ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S330 - S330
[39] Pustular psoriasis-like lesions associated with hereditary lactate dehydrogenase M subunit deficiency without interleukin-36 receptor antagonist mutation: long-term follow-up of two cases
Ito, T.
Aoshima, M.
Sugiura, K.
Fujiyama, T.
Ito, N.
Sakabe, J. I.
Akiyama, M.
Maekawa, M.
Tokura, Y.
BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (06) : 1674 - 1676
[40] Total and acylated ghrelin plasma levels as potential long-term response markers in alcohol-dependent patients receiving high-dose of the GABA-B receptor agonist baclofen
Geisel, Olga
Hellweg, Rainer
Wernecke, Klaus-Dieter
Wiedemann, Klaus
Mueller, Christian A.
PSYCHIATRY RESEARCH, 2019, 272 : 431 - 437

← 1 2 3 4 5 →